Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In order to clarify the biological activities of (-)-oxetanocin G, and (-)-oxetanocin A and its carbocyclic analogue, (-)-carboxetanocin G, the inhibitory effects of triphosphate derivatives of these compounds (
OXT
-GTP,
OXT
-ATP, and C-
OXT
-GTP) on eukaryotic and viral DNA polymerases were examined. DNA polymerase alpha purified from calf thymus was weakly inhibited by
OXT
-GTP and
OXT
-ATP but strongly by C-
OXT
-GTP, the Ki value being 0.22 microM. On the other hand, rat DNA polymerase beta was not affected by these analogues. DNA polymerase gamma purified from bovine testes was very weakly inhibited by
OXT
-GTP and
OXT
-ATP, but not by C-
OXT
-GTP.
DNA polymerase
from herpes simplex virus type-II (HSV-II) was strongly inhibited by all three analogues, the Ki values ranging from 0.5 to 1.0 microM. Human immunodeficiency virus-encoded reverse transcriptase (HIV RT) was also strongly inhibited by these three analogues, the Ki value of C-
OXT
-GTP being slightly smaller than that of
OXT
-GTP or
OXT
-ATP. Analysis of products synthesized on singly primed M13 single-stranded DNA by DNA polymerase alpha, HSV-II
DNA polymerase
or HIV RT in the presence of the analogues revealed that
OXT
-GTP and C-
OXT
-GTP were incorporated into DNA and caused chain termination mainly at sites one or two nucleotides beyond the cytosine bases on the template.
...
PMID:Inhibitory effects of triphosphate derivatives of oxetanocin G and related compounds on eukaryotic and viral DNA polymerases and human immunodeficiency virus reverse transcriptase. 138 92
Oxetanocin G(9-(2-deoxy-2-hydroxymethyl-beta-D-erythro-oxetanosyl)guanine,
OXT
-G) is a potent and selective agent against human cytomegalovirus (HCMV). In this study we synthesized the triphosphate form of
OXT
-G,
OXT
-GTP, and examined its effect on the activities of HCMV
DNA polymerase
, herpes simplex type 2 (HSV-2)
DNA polymerase
and human DNA polymerase alpha.
OXT
-GTP was found to inhibit all these polymerases in a competitive manner with respect to dGTP. The Km for dGTP and the Ki for
OXT
-GTP of HCMV
DNA polymerase
were 0.86 and 0.53 mu M, respectively, while the corresponding values of DNA polymerase alpha were 2.2 and 3.6 mu M, respectively. HPLC analysis using [3H]
OXT
-G also revealed that
OXT
-G was converted to its triphosphate form 7- to 8-fold more efficiently in HCMV-infected cells than in uninfected cells. The results suggest that both the preferential phosphorylation of
OXT
-G in HCMV-infected cells and the preferential inhibition of HCMV
DNA polymerase
by
OXT
-GTP may contribute towards the selective activity of
OXT
-G against HCMV replication.
...
PMID:Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G. 185 Oct 5
Neuronal mRNA is thought to be restricted to perikaryal and dendritic compartments containing rough endoplasmic reticulum. We have used both in situ hybridization and
DNA polymerase
chain reaction methods to determine the precise intracellular distribution of
oxytocin
mRNA. Using light- and electron-microscopic detection of in situ hybridization with 5'-bromo-2'-deoxyuridine-labeled oligonucleotide probes, we found
oxytocin
mRNA in axons and Herring bodies in the lateral and ventral hypothalamus, the median eminence, and the posterior lobe of the pituitary in postpartum lactating rats. Southern blot analysis of the amplification products confirmed the presence of
oxytocin
mRNA in all three tissue samples. The present findings indicate that
oxytocin
mRNA can be transported axonally. Such transport could reflect an adventitious compartmentalization or a functional storage in Herring bodies for subsequent secretion.
...
PMID:mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract. 226 84
The novel nucleoside oxetanocin G, 9-(2-deoxy-2-hydroxymethyl-beta-D-erythro-oxetanosyl)guanine (
OXT
-G), that is a derivative of oxetanocin A, was studied in relation to its action on the synthesis of hepatitis B virus (HBV) DNA and cellular DNA in an HBV-producing cell line, HB611 (T. Tsurimoto, A. Fujiyama, and K. Matsubara, Proc. Natl. Acad. Sci. USA 84:444-448, 1987). The median effective concentration of
OXT
-G against HBV replication was 1.5 microM, and the median cytotoxic concentration was more than 1,000 microM. At the same concentration,
OXT
-G did not inhibit cellular DNA synthesis or viral RNA synthesis. Chemically synthesized
OXT
-GTP inhibited the HBV endogenous
DNA polymerase
reaction and was incorporated into HBV DNA strands at a low efficiency compared with the incorporation of dGTP. A synthetic primer-template study revealed that
OXT
-GTP was incorporated into DNA strands at a low efficiency and that further extension of the DNA strand by using the 2' position of the incorporated
OXT
-G could take place.
...
PMID:Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virions. 751 17